Yu Yong (CIK 1937482) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy GNLX (119,318 shares), Sell GNLX (605 shares), Sell GNLX (906 shares), Sell GNLX (3,219 shares), Sell GNLX (973 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | GENELUX Corp (GNLX) | Chief Scientific Officer | Buy | 119,318 | $0 |
| 2026-05-12 | GENELUX Corp (GNLX) | Chief Scientific Officer | Sell | 605 | $1,798 |
| 2026-03-26 | GENELUX Corp (GNLX) | SVP, Clinical Development | Sell | 906 | $2,193 |
| 2025-12-11 | GENELUX Corp (GNLX) | SVP, Clinical Development | Sell | 3,219 | $10,816 |
| 2025-12-11 | GENELUX Corp (GNLX) | SVP, Clinical Development | Sell | 973 | $5,225 |
| 2025-08-29 | GENELUX Corp (GNLX) | SVP, Clinical Development | Buy | 101,480 | $0 |
| 2025-05-13 | GENELUX Corp (GNLX) | VP, Clinical Trial Operations | Sell | 5,579 | $16,291 |
| 2025-04-17 | GENELUX Corp (GNLX) | VP, Clinical Trial Operations | Buy | 13,350 | $0 |
Source: SEC Form 4 filings · as of 2026-06-18